The Ensign Group, Inc. adopted amended and restated bylaws to align with Delaware law developments and clarify Board powers. The updates revise procedural mechanics for stockholder nominations and proposals, including notice timeframes of 90 to 120 days prior to the annual meeting anniversary. Director candidates must now be available for Board interviews. These changes became effective immediately upon approval on August 20, 2026. For the 2027 Annual Meeting, written notices for director nominations or proposals must be received between January 13, 2027, and February 12, 2027. The company operates in the healthcare industry, specifically providing post-acute care services.

The Ensign Group, Inc. entered into a Fourth Amended and Restated Credit Agreement on August 19, 2026, increasing its revolving credit facility by $200 million to an aggregate principal amount of up to $800 million. The transaction extends the maturity date to August 19, 2031, providing enhanced liquidity to support acquisitions and capital investments. Borrowings are secured by liens on assets and guaranteed by domestic subsidiaries, with interest rates based on SOFR or base rate plus applicable margins determined by leverage ratios. Truist Bank serves as administrative agent for the lending syndicate. The Ensign Group operates in the post-acute healthcare sector, providing skilled nursing, senior living, and rehabilitative therapy services.

The Ensign Group, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026. The company reported GAAP diluted earnings per share of $1.68 and adjusted diluted earnings per share of $1.92, representing increases of 16.7% and 20.8% respectively over the prior year quarter. Consolidated revenue rose 17.3% year-over-year to $1.44 billion. Due to strong performance, the company raised its 2026 annual earnings guidance to a range of $7.75 to $7.85 per diluted share and increased annual revenue guidance to $5.87 billion to $5.92 billion. The company also announced a quarterly cash dividend of $0.065 per share. The Ensign Group provides post-acute healthcare services, primarily in skilled nursing and senior living facilities.

The Ensign Group, Inc. Board of Directors approved a $60 million increase to its existing $40 million stock repurchase program, increasing the total authorized capacity to $100 million. The Company may conduct repurchases through open market or privately negotiated transactions. The Ensign Group, Inc. provides post-acute healthcare services.

The Ensign Group, Inc. Board of Directors approved a new $40,000,000 stock repurchase program on May 13, 2026. This program will begin after the current repurchase program expires and allows for open market or privately negotiated transactions. The Ensign Group, Inc. provides post-acute healthcare services.